|
TET1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.298300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.816100E-02 |
| Normal-vs-Stage2 |
1.021780E-03 |
| Normal-vs-Stage3 |
3.001700E-02 |
| Normal-vs-Stage4 |
4.034400E-04 |
| Stage1-vs-Stage2 |
1.849640E-02 |
| Stage1-vs-Stage3 |
4.352000E-01 |
| Stage1-vs-Stage4 |
4.678300E-03 |
| Stage2-vs-Stage3 |
1.949560E-01 |
| Stage2-vs-Stage4 |
9.764200E-01 |
| Stage3-vs-Stage4 |
1.425960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.481400E-03 |
| Normal-vs-AfricanAmerican |
2.420000E-02 |
| Normal-vs-Asian |
5.867200E-01 |
| Caucasian-vs-AfricanAmerican |
8.242800E-01 |
| Caucasian-vs-Asian |
6.762400E-01 |
| AfricanAmerican-vs-Asian |
5.731000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.046400E-02 |
| Normal-vs-Female |
9.441900E-04 |
| Male-vs-Female |
2.162300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.386000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.165600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.037700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.984400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.215200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.093800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.870830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.550000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.983200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.332400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.505800E-01 |
| Normal-vs-Grade 2 |
9.652400E-02 |
| Normal-vs-Grade 3 |
1.424980E-03 |
| Normal-vs-Grade 4 |
4.444500E-03 |
| Grade 1-vs-Grade 2 |
3.172200E-01 |
| Grade 1-vs-Grade 3 |
1.632760E-01 |
| Grade 1-vs-Grade 4 |
1.834980E-01 |
| Grade 2-vs-Grade 3 |
2.914300E-02 |
| Grade 2-vs-Grade 4 |
9.686500E-02 |
| Grade 3-vs-Grade 4 |
8.292600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.135800E-03 |
| Normal-vs-ccB subtype |
2.093200E-01 |
| ccA subtype-vs-ccB subtype |
7.234500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.781400E-03 |
| Normal-vs-N1 |
1.980090E-02 |
| N0-vs-N1 |
5.394000E-01 |
|
|
